This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Biotest Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Michael Ramroth
Chief executive officer
€2.7m
Total compensation
CEO salary percentage
20.37%
CEO tenure
19.3yrs
CEO ownership
n/a
Management average tenure
1.4yrs
Board average tenure
1.1yrs
Recent management updates
Recent updates
CEO Compensation Analysis
How has Michael Ramroth's remuneration changed compared to Biotest's earnings?
Date
Total Compensation
Salary
Company Earnings
Mar 31 2023
n/a
n/a
-€47m
Dec 31 2022
n/a
n/a
-€32m
Sep 30 2022
n/a
n/a
-€69m
Jun 30 2022
n/a
n/a
-€65m
Mar 31 2022
n/a
n/a
-€54m
Dec 31 2021
€3m
€555k
-€63m
Sep 30 2021
n/a
n/a
-€28m
Jun 30 2021
n/a
n/a
-€33m
Mar 31 2021
n/a
n/a
-€35m
Dec 31 2020
€2m
€462k
-€31m
Sep 30 2020
n/a
n/a
-€34m
Jun 30 2020
n/a
n/a
-€24m
Mar 31 2020
n/a
n/a
-€15m
Dec 31 2019
€1m
€426k
-€5m
Sep 30 2019
n/a
n/a
-€9m
Jun 30 2019
n/a
n/a
-€3m
Mar 31 2019
n/a
n/a
-€6m
Dec 31 2018
€1m
€355k
-€13m
Sep 30 2018
n/a
n/a
€18m
Jun 30 2018
n/a
n/a
€6m
Mar 31 2018
n/a
n/a
€500k
Dec 31 2017
€1m
€355k
-€16m
Sep 30 2017
n/a
n/a
-€48m
Jun 30 2017
n/a
n/a
-€47m
Mar 31 2017
n/a
n/a
-€29m
Dec 31 2016
€1m
€355k
€6m
Compensation vs Market: Michael's total compensation ($USD2.97M) is above average for companies of similar size in the UK market ($USD1.95M).
Compensation vs Earnings: Michael's compensation has increased whilst the company is unprofitable.
CEO
Michael Ramroth (61 yo)
19.3yrs
Tenure
€2,724,000
Compensation
Dr. Michael Ramroth serves as Chairman of the Management Board and CEO at Biotest Aktiengesellschaft since May 01, 2019. Dr. Ramroth serves as Chief Financial Officer at Biotest Aktiengesellschaft. He serv...
Leadership Team
Name
Position
Tenure
Compensation
Ownership
Michael Ramroth
Chairman of the Management Board & CEO
19.3yrs
€2.72m
no data
Ainhoa Zubiaga
Member of Management Board & CFO
less than a year
no data
no data
Jorg Schuttrumpf
Chief Scientific Officer & Member of the Management Board
1.4yrs
no data
no data
Peter Janssen
COO & Member of Management Board
less than a year
no data
no data
Monika Buttkereit
Head of Investor Relations
no data
no data
no data
Christina Erb
Head of Corporate HR
7.8yrs
no data
no data
Dirk Schuck
Member of Supervisory Board
1.4yrs
no data
no data
1.4yrs
Average Tenure
50yo
Average Age
Experienced Management: BIO3D's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.
Board Members
Name
Position
Tenure
Compensation
Ownership
Dirk Schuck
Member of Supervisory Board
1.1yrs
no data
no data
Uta Kemmerich-Keil
Member of Supervisory Board
1.1yrs
no data
no data
Raimon Grifols Roura
Member of Supervisory Board
less than a year
no data
no data
Bernhard R. Ehmer
Chairman of the Supervisory Board
1.1yrs
€598.00k
no data
David Bell
Member of Supervisory Board
1yr
no data
no data
Jurgen Heilmann
Employee Representative Member of Supervisory Board
11.8yrs
€44.00k
no data
1.1yrs
Average Tenure
59yo
Average Age
Experienced Board: BIO3D's board of directors are not considered experienced ( 1.1 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2023/06/26 17:13
End of Day Share Price
2023/03/29 00:00
Earnings
2023/03/31
Annual Earnings
2022/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Biotest GmbH & Co. KGaA is covered by 3 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.